GlassScriptPhysician profile
Lisa A Guthrie
NPI 1366415291
$2,391.17
in general payments reported to CMS, 2019-2025
16 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $184 · 2021: $233 · 2022: $352 · 2023: $478 · 2024: $455 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $905.97 | 2019-2025 | |
| Novo Nordisk INC | $665.37 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $280.48 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $95.40 | 2022 | |
| Glaxosmithkline, LLC. | $73.99 | 2023-2025 | Trelegy Ellipta, Shingrix |
| Endogastric Solutions, INC | $62.50 | 2019 | |
| Daiichi Sankyo INC. | $58.47 | 2020-2021 | |
| Alkermes, INC. | $56.82 | 2025 | Vivitrol |
| Lilly USA, LLC | $54.54 | 2020-2025 | Zepbound, Mounjaro |
| Phathom Pharmaceuticals, INC. | $23.06 | 2024 | Voquezna |
| Abbott Laboratories | $22.49 | 2025 | Freestyle Libre 3 |
| Amgen INC. | $22.36 | 2019 | |
| Shield Therapeutics INC | $19.84 | 2024 | |
| Cequr Corporation | $19.82 | 2022 | |
| Dexcom, INC. | $16.76 | 2024 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Guthrie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.